Made possible by BGI’s Innovative DNBseq™ NGS technology and Gencove’s ImputeSeq™ bioinformatics, low pass WGS delivers more data for higher statistical power in your GWAS, pharmacogenomics or translational research projects.
- Imputation concordance with deep WGS of up to 99.5%
- Free of bias from array content
- Enhanced rare variant discovery
- Increased statistical power
- Unlimited re-analysis of raw data as science progresses
This new service turns WGS data into highly accurate variant calls across the entire genome and provides ancestry and microbiome profiles, all at the cost of a common genotyping array or less.